ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $5.38M invested in Entero Therapeutics in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$247K
2
+$222K

Top Sellers

1
-$182K
2
-$145K
3
-$65K
4
BFM
Boothbay Fund Management
New York
-$55K
5
RC
RegentAtlantic Capital
New Jersey
-$48K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.18M
2
$1.1M
3
$926K
4
$735K
5
$443K
6
$255K
7
$247K
8
$118K
9
$102K
10
$72K
11
$57K
12
$48K
13
$34K
14
$23K
15
$21K
16
$7K
17
$4K
18
$3K
19
–
20
–